LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID)

计划入组 886 人 · 首次发布于 2020 年 4 月 14 日

Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers

计划入组 360 人 · 首次发布于 2026 年 9 月 11 日

T-VEC in Non-melanoma Skin Cancer

计划入组 26 人 · 首次发布于 2018 年 3 月 8 日

Personalised melanoma cancer therapy ( BriaCell Therapeutics)

radioiodine combination therapy (melanoma/thyroid cancer)

GPR19 antagonists (metastatic melanoma/lung cancer)

MELANOMA AND SKIN CANCER TRIALS LIMITED

Australia

MELANOMA INSTITUTE AUSTRALIA

Australia

DR. LYNN E. SPITLER, MD

United States

Almirall Advances Etherna's Intratumoral mRNA Therapy LAD116 to Clinical Development for Non-Melanoma Skin Cancer

Philogen Resubmits Nidlegy Marketing Application to EMA with Extended Phase III Melanoma Data

Estrogen's Role in Tumor Growth and Immune Suppression Unveiled, Offering New Therapeutic Avenues